Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency

INTRODUCTION: Older patients with type 2 diabetes (T2D) are at increased risk of diabetic nephropathy and mild renal insufficiency. This analysis compared the anti-hyperglycemic efficacy and safety of sitagliptin with dapagliflozin in patients ≥ 65 years of age with T2D and mild renal insufficiency....

Descripción completa

Detalles Bibliográficos
Autores principales: Raji, Annaswamy, Xu, Zhi Jin, Lam, Raymond L. H., O’Neill, Edward A., Kaufman, Keith D., Engel, Samuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509009/
https://www.ncbi.nlm.nih.gov/pubmed/32852696
http://dx.doi.org/10.1007/s13300-020-00907-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509009/
https://www.ncbi.nlm.nih.gov/pubmed/32852696
http://dx.doi.org/10.1007/s13300-020-00907-w

Ejemplares similares